Starling Oncology STLNW
NASDAQ STLNW
$0.04 -0.01 (-21.32%)
As of: Sep 9, 2026 · 12:49 PM EDT

Starling Oncology (STLNW) Gross Margin Growth (3y) (2024 - 2026)

Analysis

Starling Oncology (STLNW) Gross Margin Growth (3y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Davita 11.90 Bn 11.21 Bn 1.16 Bn 122.00
2 RadNet 5.52 Bn 4.79 Bn 88.08 Mn -36.00
3 Fresenius Medical Care AG 4.79 Bn 4.09 Bn 1.52 Bn 214.00
4 Concentra Group Holdings Parent 4.28 Bn 4.12 Bn 192.10 Mn 231.00
5 Privia Health 2.57 Bn 2.16 Bn - -
6 Pediatrix Medical 2.15 Bn 1.74 Bn - -
7 Progyny 2.12 Bn 1.89 Bn 89.30 Mn 377.00
8 Surgery Partners 1.82 Bn 1.61 Bn 622.10 Mn 57.00
9 U S Physical Therapy 1.17 Bn 1.14 Bn 41.94 Mn -167.00
10 Starling Oncology 4.13 Mn -36.96 Mn 27.17 Mn -2,722.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,722.00
Mar 31, 2026 -2,799.00
Dec 31, 2025 11,470.00
Sep 30, 2025 -3,055.00
Jun 30, 2025 -3,143.00
Mar 31, 2025 -3,385.00
Dec 31, 2024 11,902.00
Sep 30, 2024 -3,705.00
Jun 30, 2024 10.00
Mar 31, 2024 -476.00